NO20005081L - Et polypeptid som omfatter aminosyren fra et N-terminalt kolinbindende protein A trunkat, vaksine avledet derav og anvendelser derav - Google Patents
Et polypeptid som omfatter aminosyren fra et N-terminalt kolinbindende protein A trunkat, vaksine avledet derav og anvendelser deravInfo
- Publication number
- NO20005081L NO20005081L NO20005081A NO20005081A NO20005081L NO 20005081 L NO20005081 L NO 20005081L NO 20005081 A NO20005081 A NO 20005081A NO 20005081 A NO20005081 A NO 20005081A NO 20005081 L NO20005081 L NO 20005081L
- Authority
- NO
- Norway
- Prior art keywords
- amino acid
- polypeptide
- binding protein
- choline binding
- acid sequence
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 8
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 8
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 8
- 101710164918 Choline-binding protein Proteins 0.000 title abstract 6
- 150000001413 amino acids Chemical class 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 6
- 102000004856 Lectins Human genes 0.000 abstract 1
- 108090001090 Lectins Proteins 0.000 abstract 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 abstract 1
- 229960001231 choline Drugs 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 239000002523 lectin Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8087898P | 1998-04-07 | 1998-04-07 | |
| US09/056,019 US6858706B2 (en) | 1998-04-07 | 1998-04-07 | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| PCT/US1999/007669 WO1999051188A2 (en) | 1998-04-07 | 1999-04-07 | A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20005081D0 NO20005081D0 (no) | 2000-10-09 |
| NO20005081L true NO20005081L (no) | 2000-12-06 |
Family
ID=26734874
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20005081A NO20005081L (no) | 1998-04-07 | 2000-10-09 | Et polypeptid som omfatter aminosyren fra et N-terminalt kolinbindende protein A trunkat, vaksine avledet derav og anvendelser derav |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JP4739521B2 (pt) |
| KR (1) | KR100638503B1 (pt) |
| CN (1) | CN1191851C (pt) |
| AU (2) | AU764811B2 (pt) |
| BR (1) | BR9909910A (pt) |
| CA (1) | CA2326388C (pt) |
| HU (1) | HUP0102306A3 (pt) |
| IL (1) | IL138939A0 (pt) |
| MX (1) | MXPA00009899A (pt) |
| NO (1) | NO20005081L (pt) |
| NZ (1) | NZ507983A (pt) |
| PL (1) | PL193132B1 (pt) |
| TR (1) | TR200003498T2 (pt) |
| WO (1) | WO1999051188A2 (pt) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| EP3020411A1 (en) | 2005-12-22 | 2016-05-18 | GlaxoSmithKline Biologicals s.a. | Vaccine |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| PT2167121E (pt) | 2007-06-26 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vacina compreendendo conjugados de polissacáridos capsulares de streptococcus pneumoniae |
| PT2271360E (pt) | 2008-04-16 | 2015-12-07 | Glaxosmithkline Biolog Sa | Vacina |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| SG194733A1 (en) | 2011-05-17 | 2013-12-30 | Glaxosmithkline Biolog Sa | Vaccine against streptococcus pneumoniae |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6592876B1 (en) * | 1993-04-20 | 2003-07-15 | Uab Research Foundation | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| DE69735715T2 (de) * | 1996-05-01 | 2007-03-29 | The Rockefeller University | Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird |
| DE69737125T3 (de) * | 1996-10-31 | 2015-02-26 | Human Genome Sciences, Inc. | Streptococcus pneumoniae-Antigene und Impfstoffe |
| US6291654B1 (en) * | 1996-11-12 | 2001-09-18 | Regents Of The University Of Minnesota | Method for isolating a C3 binding protein of streptococcus pneumoniae |
| NZ530277A (en) * | 1998-04-07 | 2005-08-26 | Medimmune Inc | Derivatives of pneumococcal choline binding proteins for vaccines |
| US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
-
1999
- 1999-04-07 JP JP2000541960A patent/JP4739521B2/ja not_active Expired - Fee Related
- 1999-04-07 AU AU34797/99A patent/AU764811B2/en not_active Ceased
- 1999-04-07 KR KR1020007011206A patent/KR100638503B1/ko not_active IP Right Cessation
- 1999-04-07 IL IL13893999A patent/IL138939A0/xx unknown
- 1999-04-07 MX MXPA00009899A patent/MXPA00009899A/es unknown
- 1999-04-07 PL PL347946A patent/PL193132B1/pl unknown
- 1999-04-07 AU AU34796/99A patent/AU3479699A/en not_active Withdrawn
- 1999-04-07 CN CNB998108545A patent/CN1191851C/zh not_active Expired - Fee Related
- 1999-04-07 WO PCT/US1999/007669 patent/WO1999051188A2/en active IP Right Grant
- 1999-04-07 HU HU0102306A patent/HUP0102306A3/hu unknown
- 1999-04-07 BR BR9909910-1A patent/BR9909910A/pt not_active Application Discontinuation
- 1999-04-07 CA CA2326388A patent/CA2326388C/en not_active Expired - Fee Related
- 1999-04-07 TR TR2000/03498T patent/TR200003498T2/xx unknown
- 1999-04-07 NZ NZ507983A patent/NZ507983A/xx not_active IP Right Cessation
-
2000
- 2000-10-09 NO NO20005081A patent/NO20005081L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9909910A (pt) | 2002-01-15 |
| KR20010052244A (ko) | 2001-06-25 |
| WO1999051188A2 (en) | 1999-10-14 |
| AU3479699A (en) | 1999-10-25 |
| CA2326388C (en) | 2014-02-04 |
| AU3479799A (en) | 1999-10-25 |
| KR100638503B1 (ko) | 2006-10-26 |
| JP2002516662A (ja) | 2002-06-11 |
| NZ507983A (en) | 2004-03-26 |
| AU764811B2 (en) | 2003-08-28 |
| CA2326388A1 (en) | 1999-10-14 |
| PL193132B1 (pl) | 2007-01-31 |
| CN1342088A (zh) | 2002-03-27 |
| PL347946A1 (en) | 2002-04-22 |
| NO20005081D0 (no) | 2000-10-09 |
| TR200003498T2 (tr) | 2001-10-22 |
| WO1999051188A3 (en) | 2001-04-19 |
| CN1191851C (zh) | 2005-03-09 |
| WO1999051188A9 (en) | 2000-10-12 |
| MXPA00009899A (es) | 2002-05-08 |
| JP4739521B2 (ja) | 2011-08-03 |
| HUP0102306A1 (hu) | 2001-09-28 |
| IL138939A0 (en) | 2001-11-25 |
| HUP0102306A3 (en) | 2008-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019210579B2 (en) | RSV F protein mutants | |
| KR102482994B1 (ko) | 사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물 | |
| EP4163291A1 (en) | Polypeptide vaccine coupled with tlr7 agonist for novel coronavirus and use thereof | |
| Liu et al. | Immunological characterizations of the nucleocapsid protein based SARS vaccine candidates | |
| RU2624041C2 (ru) | Конструкции гомодимерных белков | |
| CN102066410A (zh) | Hla-dr结合肽和它们的应用 | |
| Solioz et al. | The protective capacities of histone H1 against experimental murine cutaneous leishmaniasis | |
| PT754231E (pt) | Fragmento peptídico da proteína g do vírus respiratório sincicial, agente imunogénico, composição farmacêutica contendo-o e processo de preparação | |
| CA2408328A1 (en) | Immunogenic polypeptides encoded by mage minigenes and uses thereof | |
| ES2398492T3 (es) | Proteínas de fusión que comprenden los antígenos de rechazo tumoral NY-ESO-1 y LAGE-1 | |
| US20230338510A1 (en) | Novel coronavirus tandem epitope polypeptide vaccine and use thereof | |
| Davis et al. | Basic fibroblast growth factor induces 3T3 fibroblasts to synthesize and secrete a cyclophilin-like protein and β2-microglobulin | |
| JP2019013229A (ja) | 異種ポリペプチドを含むＣｙａＡベースのキメラタンパク質及び免疫応答の誘導におけるその使用 | |
| NO20005081L (no) | Et polypeptid som omfatter aminosyren fra et N-terminalt kolinbindende protein A trunkat, vaksine avledet derav og anvendelser derav | |
| ES2267142T3 (es) | Identificacion y clonacion de un antigeno micobacteriano que corresponde a una hemaglutinina de union a la heparina. | |
| GB9219936D0 (en) | Vaccines | |
| US7862828B2 (en) | Allergy vaccines containing hybrid polypeptides | |
| EP1849870A1 (en) | Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (IDDM) | |
| WO2000029434A3 (en) | PNEUMOCOCCAL CHOLINE BINDING PROTEINS, CbpG AND CbpD, DIAGNOSTIC AND THERAPEUTIC USES THEREOF | |
| KR102369146B1 (ko) | 코로나 백신 제형 | |
| US20230192777A1 (en) | Epitopic vaccine for african swine fever virus | |
| KR20220056817A (ko) | 사스-코로나바이러스-2 감염증 예방 또는 치료용 백신 조성물 | |
| CN114621329A (zh) | 一种t细胞表位肽复合物 | |
| CN116568324A (zh) | 融合蛋白和疫苗 | |
| CN100408595C (zh) | Sars病毒hla-a2限制性表位多肽及其应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application | ||
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |